European Journal of Heart Failure

The European Journal of Heart Failure-The Story So Far!
pp. 121-121(1)
Author: Cleland J.G.F.

The Euro Heart Failure Survey of The EUROHEART Survey Programme - A survey on the quality of care among patients with heart failure in Europe
pp. 123-132(10)
Authors: Cleland J.G.F.; Swedberg K.; Cohen-Solal A.; Cosin-Aguilar J.; Dietz R.; Follath F.; Gavazzi A.; Hobbs R.; Korewicki J.; Madeira H.C.; Preda I.; van Gilst W.H.; Widimsky J.; Mareev V.; for The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology; Mason J.; Freemantle N.; Eastaugh J.; for The Medicines Evaluation Group Centre for Health Economics University of York

Heart failure in the elderly: a diastolic problem?
pp. 133-136(4)
Authors: Lye M.; Wisniacki N.

Long-term prognosis of acute pulmonary oedema - an ominous outcome
pp. 137-144(8)
Authors: Roguin A.; Behar D.; Ben Ami H.; Reisner S.A.; Edelstein S.; Linn S.; Edoute Y.

Cardiovascular disease and outcome of acute stroke: influence of pre-existing cardiac failure
pp. 145-150(6)
Authors: Sharma J.C.; Fletcher S.; Vassallo M.; Ross I.

Doppler tissue imaging in congestive heart failure patients due to diastolic or systolic dysfunction: a comparison with Doppler echocardiography and the atrio-ventricular plane displacement technique
pp. 151-160(10)
Authors: Jarnert C.; Mejhert M.; Ring M.; Persson H.; Edner M.

Serum N-terminal atrial natriuretic peptide in adult patients late after surgical repair of atrial septal defect
pp. 161-165(5)
Authors: Iivainen T.E.; Groundstroem K.W.E.; Lahtela J.T.; Talvensaari T.J.; Pasternack A.; Uusitalo A.

Negative inotropic effects of recombinant interleukin 2 in patients without left ventricular dysfunction
pp. 167-173(7)
Authors: Tio R.A.; Nieken J.; de Vries E.G.E.; Pfeiffer C.; de Jongste M.J.L.; Pieper E.; Moshage H.; Limburg P.C.; Mulder N.H.

MIC trial: metoprolol in patients with mild to moderate heart failure: effects on ventricular function and cardiopulmonary exercise testing
pp. 175-181(7)
Authors: Genth-Zotz S.; Zotz R.J.; Sigmund M.; Hanrath P.; Hartmann D.; Bohm M.; Waagstein F.; Treese N.; Meyer J.; Darius H.

Improvement of cardiac output in patients with severe heart failure by use of ACE-inhibitors combined with the AT1-antagonist eprosartan
pp. 183-187(5)
Authors: Gremmler B.; Kunert M.; Schleiting H.; Ulbricht L.J.

The effects of l-carnitine treatment on left ventricular function and erythrocyte superoxide dismutase activity in patients with ischemic cardiomyopathy
pp. 189-193(5)
Authors: Gurlek A.; Tutar E.; Akcil E.; Dincer I.; Erol C.; Kocaturk P.A.; Oral D.

Left ventricular-based pacing in patients with chronic heart failure: comparison of acute hemodynamic benefits according to underlying heart disease
pp. 195-199(5)
Authors: Mansourati J.; Etienne Y.; Gilard M.; Valls-Bertault V.; Boschat J.; Benditt D.G.; Lurie K.G.; Blanc J.-J.

Angiotensin converting enzyme (ACE) inhibitors in the treatment of heart failure in general practice in north Cumbria
pp. 201-207(7)
Authors: Toal M.; Walker R.

Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT
pp. 209-212(4)
Authors: Thackray S.; Witte K.; Clark A.L.; Cleland J.G.F.

The HEART FAILURE Journal Club: a review of publications on heart failure in HEART
pp. 213-222(10)
Author: Witte K.

The management of patients with heart failure in France
pp. 223-226(4)
Authors: Cohen-Solal A.; Bouhour J.B.; Thebaut J.F.